• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and China Meningitis Vaccine Market Insights, Forecast to 2026

report cover
  • 4 September 2020
  • Pharmaceuticals
  • 127 Pages
  • Report Code: 24LS-21609
  • Formate :   
Download FREE Report Sample Download PDF File

Meningitis Vaccine -MARKET ADVISORY SERVICES

Meningitis Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Meningitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Meningitis Vaccine market is segmented into
Meningitis A+C
Meningitis ACWY135
Meningitis B

Segment by Application, the Meningitis Vaccine market is segmented into
Medical Care
Hospital

Regional and Country-level Analysis
The Meningitis Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Meningitis Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Meningitis Vaccine Market Share Analysis
Meningitis Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Meningitis Vaccine business, the date to enter into the Meningitis Vaccine market, Meningitis Vaccine product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Baxter International
Sanofi Pasteur
Merck
Novartis
Pfizer
Hualan
Zhejiang Tianyuan
Beijing Tiantan Biological
1 Study Coverage
1.1 Meningitis Vaccine Product Introduction
1.2 Market Segments
1.3 Key Meningitis Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Meningitis Vaccine Market Size Growth Rate by Type
1.4.2 Meningitis A+C
1.4.3 Meningitis ACWY135
1.4.4 Meningitis B
1.5 Market by Application
1.5.1 Global Meningitis Vaccine Market Size Growth Rate by Application
1.5.2 Medical Care
1.5.3 Hospital
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Meningitis Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Meningitis Vaccine Revenue 2015-2026
2.1.2 Global Meningitis Vaccine Sales 2015-2026
2.2 Global Meningitis Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Meningitis Vaccine Historical Market Size by Region (2015-2020)
2.3.1 Global Meningitis Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Meningitis Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Meningitis Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Meningitis Vaccine Sales Forecast by Region (2021-2026)
2.4.2 Global Meningitis Vaccine Revenue Forecast by Region (2021-2026)

3 Global Meningitis Vaccine Competitor Landscape by Players
3.1 Global Top Meningitis Vaccine Sales by Manufacturers
3.1.1 Global Meningitis Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Meningitis Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Meningitis Vaccine Manufacturers by Revenue
3.2.1 Global Meningitis Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Meningitis Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Meningitis Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Meningitis Vaccine Revenue in 2019
3.2.5 Global Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Meningitis Vaccine Price by Manufacturers
3.4 Global Meningitis Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Meningitis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningitis Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Meningitis Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Meningitis Vaccine Market Size by Type (2015-2020)
4.1.1 Global Meningitis Vaccine Sales by Type (2015-2020)
4.1.2 Global Meningitis Vaccine Revenue by Type (2015-2020)
4.1.3 Meningitis Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Meningitis Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Meningitis Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Meningitis Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Meningitis Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Meningitis Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Meningitis Vaccine Market Size by Application (2015-2020)
5.1.1 Global Meningitis Vaccine Sales by Application (2015-2020)
5.1.2 Global Meningitis Vaccine Revenue by Application (2015-2020)
5.1.3 Meningitis Vaccine Price by Application (2015-2020)
5.2 Meningitis Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Meningitis Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Meningitis Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Meningitis Vaccine Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
6.1 China Meningitis Vaccine Market Size YoY Growth 2015-2026
6.1.1 China Meningitis Vaccine Sales YoY Growth 2015-2026
6.1.2 China Meningitis Vaccine Revenue YoY Growth 2015-2026
6.1.3 China Meningitis Vaccine Market Share in Global Market 2015-2026
6.2 China Meningitis Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Meningitis Vaccine Players by Sales (2015-2020)
6.2.2 China Top Meningitis Vaccine Players by Revenue (2015-2020)
6.3 China Meningitis Vaccine Historic Market Review by Type (2015-2020)
6.3.1 China Meningitis Vaccine Sales Market Share by Type (2015-2020)
6.3.2 China Meningitis Vaccine Revenue Market Share by Type (2015-2020)
6.3.3 China Meningitis Vaccine Price by Type (2015-2020)
6.4 China Meningitis Vaccine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Meningitis Vaccine Sales Forecast by Type (2021-2026)
6.4.2 China Meningitis Vaccine Revenue Forecast by Type (2021-2026)
6.4.3 China Meningitis Vaccine Price Forecast by Type (2021-2026)
6.5 China Meningitis Vaccine Historic Market Review by Application (2015-2020)
6.5.1 China Meningitis Vaccine Sales Market Share by Application (2015-2020)
6.5.2 China Meningitis Vaccine Revenue Market Share by Application (2015-2020)
6.5.3 China Meningitis Vaccine Price by Application (2015-2020)
6.6 China Meningitis Vaccine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Meningitis Vaccine Sales Forecast by Application (2021-2026)
6.6.2 China Meningitis Vaccine Revenue Forecast by Application (2021-2026)
6.6.3 China Meningitis Vaccine Price Forecast by Application (2021-2026)

7 North America
7.1 North America Meningitis Vaccine Market Size YoY Growth 2015-2026
7.2 North America Meningitis Vaccine Market Facts & Figures by Country
7.2.1 North America Meningitis Vaccine Sales by Country (2015-2020)
7.2.2 North America Meningitis Vaccine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Meningitis Vaccine Market Size YoY Growth 2015-2026
8.2 Europe Meningitis Vaccine Market Facts & Figures by Country
8.2.1 Europe Meningitis Vaccine Sales by Country
8.2.2 Europe Meningitis Vaccine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Meningitis Vaccine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Meningitis Vaccine Market Facts & Figures by Country
9.2.1 Asia Pacific Meningitis Vaccine Sales by Region (2015-2020)
9.2.2 Asia Pacific Meningitis Vaccine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Meningitis Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Meningitis Vaccine Market Facts & Figures by Country
10.2.1 Latin America Meningitis Vaccine Sales by Country
10.2.2 Latin America Meningitis Vaccine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Meningitis Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Meningitis Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Meningitis Vaccine Sales by Country
11.2.2 Middle East and Africa Meningitis Vaccine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Meningitis Vaccine Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Baxter International
12.2.1 Baxter International Corporation Information
12.2.2 Baxter International Description and Business Overview
12.2.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Baxter International Meningitis Vaccine Products Offered
12.2.5 Baxter International Recent Development
12.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Corporation Information
12.3.2 Sanofi Pasteur Description and Business Overview
12.3.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Pasteur Meningitis Vaccine Products Offered
12.3.5 Sanofi Pasteur Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Description and Business Overview
12.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck Meningitis Vaccine Products Offered
12.4.5 Merck Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Description and Business Overview
12.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Meningitis Vaccine Products Offered
12.5.5 Novartis Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Description and Business Overview
12.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer Meningitis Vaccine Products Offered
12.6.5 Pfizer Recent Development
12.7 Hualan
12.7.1 Hualan Corporation Information
12.7.2 Hualan Description and Business Overview
12.7.3 Hualan Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hualan Meningitis Vaccine Products Offered
12.7.5 Hualan Recent Development
12.8 Zhejiang Tianyuan
12.8.1 Zhejiang Tianyuan Corporation Information
12.8.2 Zhejiang Tianyuan Description and Business Overview
12.8.3 Zhejiang Tianyuan Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Zhejiang Tianyuan Meningitis Vaccine Products Offered
12.8.5 Zhejiang Tianyuan Recent Development
12.9 Beijing Tiantan Biological
12.9.1 Beijing Tiantan Biological Corporation Information
12.9.2 Beijing Tiantan Biological Description and Business Overview
12.9.3 Beijing Tiantan Biological Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Beijing Tiantan Biological Meningitis Vaccine Products Offered
12.9.5 Beijing Tiantan Biological Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GlaxoSmithKline Meningitis Vaccine Products Offered
12.11.5 GlaxoSmithKline Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Meningitis Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Meningitis Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Meningitis Vaccine Market Segments

Table 2. Ranking of Global Top Meningitis Vaccine Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Meningitis Vaccine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)

Table 4. Major Manufacturers of Meningitis A+C

Table 5. Major Manufacturers of Meningitis ACWY135

Table 6. Major Manufacturers of Meningitis B

Table 7. Global Meningitis Vaccine Market Size Growth Rate by Application 2020-2026 (K MT)

Table 8. Global Meningitis Vaccine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026

Table 9. Global Meningitis Vaccine Sales by Regions 2015-2020 (K MT)

Table 10. Global Meningitis Vaccine Sales Market Share by Regions (2015-2020)

Table 11. Global Meningitis Vaccine Revenue by Regions 2015-2020 (US$ Million)

Table 12. Global Meningitis Vaccine Sales Forecast by Region (2021-2026) (K MT)

Table 13. Global Meningitis Vaccine Sales by Manufacturers (2015-2020) (K MT)

Table 14. Global Meningitis Vaccine Sales Share by Manufacturers (2015-2020)

Table 15. Global Meningitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 16. Global Meningitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningitis Vaccine as of 2019)

Table 17. Meningitis Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)

Table 18. Meningitis Vaccine Revenue Share by Manufacturers (2015-2020)

Table 19. Key Manufacturers Meningitis Vaccine Price (2015-2020) (USD/MT)

Table 20. Meningitis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 21. Manufacturers Meningitis Vaccine Product Type

Table 22. Date of International Manufacturers Enter into Meningitis Vaccine Market

Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 24. Global Meningitis Vaccine Sales by Type (2015-2020) (K MT)

Table 25. Global Meningitis Vaccine Sales Share by Type (2015-2020)

Table 26. Global Meningitis Vaccine Revenue by Type (2015-2020) (US$ Million)

Table 27. Global Meningitis Vaccine Revenue Share by Type (2015-2020)

Table 28. Meningitis Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)

Table 29. Global Meningitis Vaccine Sales Share by Type (2021-2026)

Table 30. Global Meningitis Vaccine Sales by Application (2015-2020) (K MT)

Table 31. Global Meningitis Vaccine Sales Share by Application (2015-2020)

Table 32. Global Meningitis Vaccine Sales Share by Application (2021-2026)

Table 33. Global Meningitis Vaccine Sales Market Share Forecast by Application (2021-2026)

Table 34. Global Meningitis Vaccine Revenue by Application (2015-2020) (US$ Million)

Table 35. Global Meningitis Vaccine Revenue Market Share Forecast by Application (2021-2026)

Table 36. China Meningitis Vaccine Sales (K MT) of Key Companies (2015-2020)

Table 37. China Meningitis Vaccine Sales Share by Company (2015-2020)

Table 38. China Meningitis Vaccine Revenue (US$ Million) by Company (2015-2020)

Table 39. China Meningitis Vaccine Sales (K MT) by Type (2015-2020)

Table 40. China Meningitis Vaccine Sales Share by Type (2015-2020)

Table 41. China Meningitis Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)

Table 42. China Meningitis Vaccine Price (K MT) by Type (2015-2020)

Table 43. China Meningitis Vaccine Sales (K MT) by Type (2021-2026)

Table 44. China Meningitis Vaccine Sales Share by Type (2021-2026)

Table 45. China Meningitis Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)

Table 46. China Meningitis Vaccine Revenue Share by Type (2021-2026)

Table 47. China Meningitis Vaccine Price (K MT) by Type (2021-2026)

Table 48. China Meningitis Vaccine Sales (K MT) by Application (2015-2020)

Table 49. China Meningitis Vaccine Sales Share by Application (2015-2020)

Table 50. China Meningitis Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)

Table 51. China Meningitis Vaccine Sales (K MT) by Application (2021-2026)

Table 52. China Meningitis Vaccine Sales Share by Application (2021-2026)

Table 53. China Meningitis Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)

Table 54. China Meningitis Vaccine Revenue Share by Application (2021-2026)

Table 55. North America Meningitis Vaccine Sales by Country (2015-2020) (K MT)

Table 56. North America Meningitis Vaccine Sales Market Share by Country (2015-2020)

Table 57. North America Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 58. North America Meningitis Vaccine Revenue Market Share by Country (2015-2020)

Table 59. Europe Meningitis Vaccine Sales by Country (2015-2020) (K MT)

Table 60. Europe Meningitis Vaccine Sales Market Share by Country (2015-2020)

Table 61. Europe Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 62. Europe Meningitis Vaccine Revenue Market Share by Country (2015-2020)

Table 63. Asia Pacific Meningitis Vaccine Sales by Region (2015-2020) (K MT)

Table 64. Asia Pacific Meningitis Vaccine Sales Market Share by Region (2015-2020)

Table 65. Asia Pacific Meningitis Vaccine Revenue by Region (2015-2020) (US$ Million)

Table 66. Asia Pacific Meningitis Vaccine Revenue Market Share by Region (2015-2020)

Table 67. Latin America Meningitis Vaccine Sales by Country (2015-2020) (K MT)

Table 68. Latin America Meningitis Vaccine Sales Market Share by Country (2015-2020)

Table 69. Latin Americaa Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 70. Latin America Meningitis Vaccine Revenue Market Share by Country (2015-2020)

Table 71. Middle East and Africa Meningitis Vaccine Sales by Country (2015-2020) (K MT)

Table 72. Middle East and Africa Meningitis Vaccine Sales Market Share by Country (2015-2020)

Table 73. Middle East and Africa Meningitis Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 74. Middle East and Africa Meningitis Vaccine Revenue Market Share by Country (2015-2020)

Table 75. GlaxoSmithKline Corporation Information

Table 76. GlaxoSmithKline Description and Business Overview

Table 77. GlaxoSmithKline Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 78. GlaxoSmithKline Meningitis Vaccine Product

Table 79. GlaxoSmithKline Recent Development

Table 80. Baxter International Corporation Information

Table 81. Baxter International Description and Business Overview

Table 82. Baxter International Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 83. Baxter International Product

Table 84. Baxter International Recent Development

Table 85. Sanofi Pasteur Corporation Information

Table 86. Sanofi Pasteur Description and Business Overview

Table 87. Sanofi Pasteur Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 88. Sanofi Pasteur Product

Table 89. Sanofi Pasteur Recent Development

Table 90. Merck Corporation Information

Table 91. Merck Description and Business Overview

Table 92. Merck Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 93. Merck Product

Table 94. Merck Recent Development

Table 95. Novartis Corporation Information

Table 96. Novartis Description and Business Overview

Table 97. Novartis Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 98. Novartis Product

Table 99. Novartis Recent Development

Table 100. Pfizer Corporation Information

Table 101. Pfizer Description and Business Overview

Table 102. Pfizer Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 103. Pfizer Product

Table 104. Pfizer Recent Development

Table 105. Hualan Corporation Information

Table 106. Hualan Description and Business Overview

Table 107. Hualan Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 108. Hualan Product

Table 109. Hualan Recent Development

Table 110. Zhejiang Tianyuan Corporation Information

Table 111. Zhejiang Tianyuan Description and Business Overview

Table 112. Zhejiang Tianyuan Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 113. Zhejiang Tianyuan Product

Table 114. Zhejiang Tianyuan Recent Development

Table 115. Beijing Tiantan Biological Corporation Information

Table 116. Beijing Tiantan Biological Description and Business Overview

Table 117. Beijing Tiantan Biological Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 118. Beijing Tiantan Biological Product

Table 119. Beijing Tiantan Biological Recent Development

Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 121. Key Challenges

Table 122. Market Risks

Table 123. Main Points Interviewed from Key Meningitis Vaccine Players

Table 124. Meningitis Vaccine Customers List

Table 125. Meningitis Vaccine Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Meningitis Vaccine Product Picture

Figure 2. Global Meningitis Vaccine Sales Market Share by Type in 2020 & 2026

Figure 3. Meningitis A+C Product Picture

Figure 4. Meningitis ACWY135 Product Picture

Figure 5. Meningitis B Product Picture

Figure 6. Global Meningitis Vaccine Sales Market Share by Application in 2020 & 2026

Figure 7. Medical Care

Figure 8. Hospital

Figure 9. Meningitis Vaccine Report Years Considered

Figure 10. Global Meningitis Vaccine Market Size 2015-2026 (US$ Million)

Figure 11. Global Meningitis Vaccine Sales 2015-2026 (K MT)

Figure 12. Global Meningitis Vaccine Market Size Market Share by Region: 2020 Versus 2026

Figure 13. Global Meningitis Vaccine Sales Market Share by Region (2015-2020)

Figure 14. Global Meningitis Vaccine Sales Market Share by Region in 2019

Figure 15. Global Meningitis Vaccine Revenue Market Share by Region (2015-2020)

Figure 16. Global Meningitis Vaccine Revenue Market Share by Region in 2019

Figure 17. Global Meningitis Vaccine Sales Share by Manufacturer in 2019

Figure 18. The Top 10 and 5 Players Market Share by Meningitis Vaccine Revenue in 2019

Figure 19. Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 20. Global Meningitis Vaccine Sales Market Share by Type (2015-2020)

Figure 21. Global Meningitis Vaccine Sales Market Share by Type in 2019

Figure 22. Global Meningitis Vaccine Revenue Market Share by Type (2015-2020)

Figure 23. Global Meningitis Vaccine Revenue Market Share by Type in 2019

Figure 24. Global Meningitis Vaccine Market Share by Price Range (2015-2020)

Figure 25. Global Meningitis Vaccine Sales Market Share by Application (2015-2020)

Figure 26. Global Meningitis Vaccine Sales Market Share by Application in 2019

Figure 27. Global Meningitis Vaccine Revenue Market Share by Application (2015-2020)

Figure 28. Global Meningitis Vaccine Revenue Market Share by Application in 2019

Figure 29. China Meningitis Vaccine Sales Growth Rate 2015-2026 (K MT)

Figure 30. China Meningitis Vaccine Revenue Growth Rate 2015-2026 (US$ Million)

Figure 31. China Meningitis Vaccine Market Share in Global Market 2015-2026

Figure 32. China 5 and 10 Largest Meningitis Vaccine Players Market Share by Revenue in Meningitis Vaccine in 2019

Figure 33. China Meningitis Vaccine Revenue Share by Type (2015-2020)

Figure 34. China Meningitis Vaccine Revenue Growth Rate by Type in 2015 & 2019

Figure 35. China Meningitis Vaccine Revenue Share by Application (2015-2020)

Figure 36. China Meningitis Vaccine Revenue Growth Rate by Application in 2015 & 2019

Figure 37. North America Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)

Figure 38. North America Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 39. North America Meningitis Vaccine Sales Market Share by Country in 2019

Figure 40. North America Meningitis Vaccine Revenue Market Share by Country in 2019

Figure 41. U.S. Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 42. U.S. Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 43. Canada Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 44. Canada Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 45. Europe Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)

Figure 46. Europe Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 47. Europe Meningitis Vaccine Sales Market Share by Country in 2019

Figure 48. Europe Meningitis Vaccine Revenue Market Share by Country in 2019

Figure 49. Germany Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 50. Germany Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 51. France Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 52. France Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. U.K. Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 54. U.K. Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. Italy Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 56. Italy Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Russia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 58. Russia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Asia Pacific Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)

Figure 60. Asia Pacific Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 61. Asia Pacific Meningitis Vaccine Sales Market Share by Region in 2019

Figure 62. Asia Pacific Meningitis Vaccine Revenue Market Share by Region in 2019

Figure 63. China Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 64. China Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 65. Japan Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 66. Japan Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. South Korea Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 68. South Korea Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. India Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 70. India Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. Australia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 72. Australia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Taiwan Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 74. Taiwan Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Indonesia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 76. Indonesia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Thailand Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 78. Thailand Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Malaysia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 80. Malaysia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Philippines Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 82. Philippines Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Vietnam Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 84. Vietnam Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Latin America Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)

Figure 86. Latin America Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 87. Latin America Meningitis Vaccine Sales Market Share by Country in 2019

Figure 88. Latin America Meningitis Vaccine Revenue Market Share by Country in 2019

Figure 89. Mexico Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 90. Mexico Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 91. Brazil Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 92. Brazil Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 93. Argentina Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 94. Argentina Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Middle East and Africa Meningitis Vaccine Sales Growth Rate 2015-2020 (K MT)

Figure 96. Middle East and Africa Meningitis Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 97. Middle East and Africa Meningitis Vaccine Sales Market Share by Country in 2019

Figure 98. Middle East and Africa Meningitis Vaccine Revenue Market Share by Country in 2019

Figure 99. Turkey Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 100. Turkey Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 101. Saudi Arabia Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 102. Saudi Arabia Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 103. U.A.E Meningitis Vaccine Sales Growth Rate (2015-2020) (K MT)

Figure 104. U.A.E Meningitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 105. Porter's Five Forces Analysis

Figure 106. Meningitis Vaccine Value Chain

Figure 107. Channels of Distribution

Figure 108. Distributors Profiles

Figure 109. Bottom-up and Top-down Approaches for This Report

Figure 110. Data Triangulation

Figure 111. Key Executives Interviewed

GlaxoSmithKline

Baxter International

Sanofi Pasteur

Merck

Novartis

Pfizer

Hualan

Zhejiang Tianyuan

Beijing Tiantan Biological

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3120

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase